iCRT-5 is a beta-catenin-regulated transcription (CRT) inhibitor. iCRT-5 can block Wnt/beta-catenin reporter activity and down regulate beta-catenin expression. iCRT-5 can be used for the research of multiple myeloma[1][2].
Molecular Weight:
367.44
Purity:
99.1
CAS Number:
[18623-44-4]
Formula:
C16H17NO5S2
Target:
Wnt,beta-catenin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted